REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 24th, 2019 • BridgeBio Pharma, Inc. • Pharmaceutical preparations • Delaware
This Registration Rights Agreement (this “Agreement”) is made and entered into as of [•], 2019 by and among BridgeBio Pharma, Inc., a Delaware corporation (the “Company”), and each of the holders of Registrable Securities listed on Schedule A hereto, which shall include KKR and Viking, each of which is referred to in this Agreement as a “Holder,” and any additional holders that becomes a party to this Agreement in accordance with Section 4.1 hereof.
BRIDGEBIO PHARMA, INC. DIRECTOR INDEMNIFICATION AGREEMENTBridgebio Pharma • June 24th, 2019 • BridgeBio Pharma, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made as of [__________], 201[_] by and between BridgeBio Pharma, Inc., a Delaware corporation (the “Company”), and [__________] (“Indemnitee”).
BridgeBio Pharma, Inc. BridgeBio Pharma LLC Common Stock Underwriting AgreementUnderwriting Agreement • June 24th, 2019 • BridgeBio Pharma, Inc. • Pharmaceutical preparations • New York
BridgeBio Pharma, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [•] shares of the Company’s common stock, par value $0.001 per share (“Stock”, and such shares, the “Firm Shares”) and, at the election of the Underwriters, up to [•] additional shares (the “Optional Shares”) of Stock (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
TAX SHARING AGREEMENTTax Sharing Agreement • June 24th, 2019 • BridgeBio Pharma, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT is entered into by and among BridgeBio Pharma, Inc. (“BridgeBio”), [SUBSIDIARY] (“[SUBSIDIARY]”), and each of the undersigned affiliates (the “Affiliates”, or in the singular “Affiliate”), collectively the “Parties” and each individually, a “Party” as of [ ].
INDEMNIFICATION AGREEMENTIndemnification Agreement • June 24th, 2019 • BridgeBio Pharma, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (this “Agreement”) is entered into as of the 26th day of March, 2016 by BridgeBio Pharma LLC, a Delaware limited liability company (including any successor thereof) (the “Company”), for the benefit of KKR Genetic Disorder L.P., a Delaware limited partnership (“KKR”) and its Affiliates (each, an “Indemnitee” and collectively, the “Indemnitees”).
